Symptoms related to the menstrual cycle: Diagnosis, prevalence, and treatment

被引:53
作者
Clayton, Anita H. [1 ]
机构
[1] Univ Virginia Hlth Syst, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA
关键词
dysmenorrhea; premenstrual symptoms; premenstrual dysphoric disorder; menstrual cycle-related symptoms; menstruation; nonsteroidal anti-inflammatory drugs; selective serotonin reuptake inhibitors; ovulation suppression; oral contraceptives; nutritional supplements;
D O I
10.1097/01.pra.0000308491.54885.f8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Menstrual cycle-related symptoms are associated with the intrinsic hormonal fluctuations of the menstrual cycle. These symptoms can be physical, behavioral, or emotional and include problems such as dysmenorrhea, premenstrual syndrome (PMS), and premenstrual dysphoric disorder (PMDD). Because of the emotional and behavioral aspects of menstrual cycle-related symptoms, it is likely that clinical psychiatrists will encounter these symptoms in their daily practice and should therefore be familiar with their diagnosis, prevalence, etiology, and treatment. As many as 2.5 million women are affected by menstrual disorders each year, which can have a profound impact on their quality of life. Although a definitive etiology has yet to be established, fluctuations in estrogen and progesterone, as well as genetic factors are thought to contribute to the occurrence of menstrual disorders. Current treatment options include nonsteroidal anti-inflammatory drugs (NSAIDs) (for dysmenorrhea), lifestyle changes, selective serotonin reuptake inhibitors (SSRIs), and ovulation suppression (e.g., with oral contraceptives). Treatment with oral contraceptives (OCs), particularly extended or continuous use, may significantly reduce the incidence of menstrual cycle-related symptoms.
引用
收藏
页码:13 / 21
页数:9
相关论文
共 80 条
[1]  
*AM COLL OBST GYN, 2000, ACOG PRACT B, V15, P448
[2]  
[Anonymous], 2001, ADV PSYCHIAT TREAT, DOI DOI 10.1192/APT.7.6.469
[3]  
[Anonymous], 2003, International classification of diseases, V10th
[4]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[5]  
ASHTON AK, 2003, J FAM PRACT S, pS48
[6]   ORAL-CONTRACEPTIVES IN PREMENSTRUAL-SYNDROME - A RANDOMIZED COMPARISON OF TRIPHASIC AND MONOPHASIC PREPARATIONS [J].
BACKSTROM, T ;
HANSSONMALMSTROM, Y ;
LINDHE, BA ;
CAVALLIBJORKMAN, B ;
NORDENSTROM, S .
CONTRACEPTION, 1992, 46 (03) :253-268
[7]  
Backström T, 2003, CNS DRUGS, V17, P325
[8]  
Bhatia SC, 2002, AM FAM PHYSICIAN, V66, P1239
[9]   Estimating direct and indirect costs of premenstrual syndrome [J].
Borenstein, J ;
Chiou, CF ;
Dean, B ;
Wong, J ;
Wade, S .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2005, 47 (01) :26-33
[10]  
Borenstein JE, 2003, J REPROD MED, V48, P515